Roivant Sciences (ROIV) Current Assets (2021 - 2026)

Roivant Sciences has reported Current Assets for 6 years, with the latest figure at $5.2 billion in Q1 2026.

• For the quarter ending Q1 2026, Current Assets rose 3.35% year-over-year to $5.2 billion; the trailing twelve-month figure through Mar 2026 stood at $5.2 billion (up 3.35% YoY), and the FY2026 full-year result was $5.2 billion, up 3.35% from the prior year.
• Current Assets for Q1 2026 stood at $5.2 billion, up from $461.5 million in the prior quarter.
• The five-year high for Current Assets was $6.7 billion in Q1 2024, with the low at $461.5 million in Q4 2025.
• Historically, Current Assets has averaged $3.1 billion across 5 years, with a median of $2.0 billion in 2022.
• Annual changes were most pronounced in 2023 — Current Assets tumbled 61.39% — and 2024, when it soared 284.43%.
• Roivant Sciences' Current Assets stood at $1.6 billion in 2022, then slumped by 61.39% to $635.7 million in 2023, then increased by 3.33% to $656.8 million in 2024, then fell by 29.74% to $461.5 million in 2025, then soared by 1019.79% to $5.2 billion in 2026.
• The last three Current Assets figures came in at $5.2 billion (Q1 2026), $461.5 million (Q4 2025), and $4.5 billion (Q3 2025), per Business Quant data.